Inside BENEO’s new pulse plant: pioneering sustainable protein from faba beans
The Rs 25 crore facility will produce powdered liposomal vitamins and minerals, botanically enriched beadlets, and customised formulations
Botanic Healthcare has launched its dedicated Liposomal Manufacturing Facility in Hyderabad with an investment of over Rs 25 crore. The expansion marks a significant milestone in advancing delivery technologies designed to enhance bioavailability and effectiveness across various health and wellness categories.
With a raw material capacity of over 8,500 metric tonne annually, the LipsoBio facility will produce powdered liposomal vitamins and minerals, botanically enriched beadlets, and customised formulations. The unit incorporates Botanic Healthcare’s patent-filed DFS (Dietary Fiber Stabilized) Technology, which enables superior stability and consistent performance in liposomal formats. This combination of cutting-edge technology and strict quality protocols ensures the company’s liposomal products meet international regulatory standards and deliver consistent performance for nutraceutical, pharmaceutical, cosmeceutical, and functional food applications.
“This facility is more than an expansion of capacity; it is a milestone in our journey to redefine how natural ingredients are delivered to consumers,” said Madhu Krishnamani, Founder and Managing Director, Botanic Healthcare. “By combining advanced science with our commitment to quality, LipsoBio will enable partners to launch next-generation health solutions with clinically proven benefits.”
The new unit has already created over 50 high-value jobs across R&D, manufacturing, and quality operations, while also generating indirect opportunities for local suppliers and vendors.
Leading companies worldwide are incorporating Botanic Healthcare’s LipsoBio liposomal ingredients into their formulations and successfully launching products that are generating strong market returns. Our innovative portfolio, including, LipoGlo (Liposomal Glutathione), LipoQ10™ (Liposomal CoQ10), and Lipomac™ (Liposomal Vitamin C) is creating measurable impact across markets. A leading Korean company has recently launched LipsoBio. The growing adoption of our liposomal solutions highlights the trust global partners place in our science-driven technologies and reinforces Botanic Healthcare’s leadership in advancing the future of nutraceutical innovation,” said Dr HN Shivaprasad, Chief Scientific Officer, Botanic Healthcare.
The facility has been designed with sustainability at its core, featuring energy-efficient systems, water recycling, and responsible waste management. Botanic Healthcare also prioritises renewable energy integration and sustainable sourcing, ensuring growth aligns with environmental stewardship and social responsibility.
Strategically designed to serve both domestic and international markets, LipsoBio strengthens Botanic Healthcare’s supply network across South Korea, Taiwan, North America, Europe, and Asia-Pacific.
With integrated R&D and pilot-scale facilities, the new unit also accelerates product development, enabling the company to bring innovative formulations to market more quickly and efficiently.